Harvard's Wyss Institute collaborates with GBS Inc. on eRapid-based COVID-19 diagnostic

(Wyss Institute for Biologically Inspired Engineering at Harvard) The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute's eRapid technology with the company's proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news